Search

Your search keyword '"Sebti, Said"' showing total 895 results
Start Over Author "Sebti, Said"
895 results on '"Sebti, Said"'

3. Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair

Author

Walton, Kelly, Walker, Kirsti, Riddle, Megan, Koehn, Brent H., Reff, Jordan, Sagatys, Elizabeth M., Linden, Michael A., Pidala, Joseph, Kim, Jongphil, Lee, Marie C., Kiluk, John V., Hui, Jane Yuet Ching, Yun, Sang Y., Xing, Yan, Stefanski, Heather, Lawrence, Harshani R., Lawrence, Nicholas J., Tolar, Jakub, Anasetti, Claudio, Blazar, Bruce R., Sebti, Said M., and Betts, Brian C.

Published
2022
Full Text
View/download PDF

5. Correction: Porphyrin overdrive rewires cancer cell metabolism

Author

Adapa, Swamy R, primary, Hunter, Gregory A, additional, Amin, Narmin E, additional, Marinescu, Christopher, additional, Borsky, Andrew, additional, Sagatys, Elizabeth M, additional, Sebti, Said M, additional, Reuther, Gary W, additional, Ferreira, Gloria C, additional, and Jiang, Rays HY, additional

Published
2024
Full Text
View/download PDF

8. Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors

Author

Kazi, Aslamuzzaman, primary, Ranjan, Alok, additional, Kumar M.V., Vasantha, additional, Agianian, Bogos, additional, Garcia Chavez, Martin, additional, Vudatha, Vignesh, additional, Wang, Rui, additional, Vangipurapu, Rajanikanth, additional, Chen, Liwei, additional, Kennedy, Perry, additional, Subramanian, Karthikeyan, additional, Quirke, Jonathan C.K., additional, Beato, Francisca, additional, Underwood, Patrick W., additional, Fleming, Jason B., additional, Trevino, Jose, additional, Hergenrother, Paul J., additional, Gavathiotis, Evripidis, additional, and Sebti, Said M., additional

Published
2023
Full Text
View/download PDF

14. Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine

Author

Carbone, Michele, Amelio, Ivano, Affar, El Bachir, Brugarolas, James, Cannon-Albright, Lisa A, Cantley, Lewis C., Cavenee, Webster K., Chen, Zhijian, Croce, Carlo M., Andrea, Alan D’, Gandara, David, Giorgi, Carlotta, Jia, Wei, Lan, Qing, Mak, Tak Wah, Manley, James L., Mikoshiba, Katsuhiko, Onuchic, Jose N, Pass, Harvey I., Pinton, Paolo, Prives, Carol, Rothman, Nathaniel, Sebti, Said M., Turkson, James, Wu, Xifeng, Yang, Haining, Yu, Herbert, and Melino, Gerry

Published
2018
Full Text
View/download PDF

17. Supplementary Data from CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function

Author

Boucher, Justin C., primary, Li, Gongbo, primary, Kotani, Hiroshi, primary, Cabral, Maria L., primary, Morrissey, Dylan, primary, Lee, Sae Bom, primary, Spitler, Kristen, primary, Beatty, Nolan J., primary, Cervantes, Estelle V., primary, Shrestha, Bishwas, primary, Yu, Bin, primary, Kazi, Aslamuzzaman, primary, Wang, Xuefeng, primary, Sebti, Said M., primary, and Davila, Marco L., primary

Published
2023
Full Text
View/download PDF

18. Data from CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function

Author

Boucher, Justin C., primary, Li, Gongbo, primary, Kotani, Hiroshi, primary, Cabral, Maria L., primary, Morrissey, Dylan, primary, Lee, Sae Bom, primary, Spitler, Kristen, primary, Beatty, Nolan J., primary, Cervantes, Estelle V., primary, Shrestha, Bishwas, primary, Yu, Bin, primary, Kazi, Aslamuzzaman, primary, Wang, Xuefeng, primary, Sebti, Said M., primary, and Davila, Marco L., primary

Published
2023
Full Text
View/download PDF

19. Data from Chk1 Inhibition Potently Blocks STAT3 Tyrosine705 Phosphorylation, DNA-Binding Activity, and Activation of Downstream Targets in Human Multiple Myeloma Cells

Author

Zhou, Liang, primary, Pei, Xinyan, primary, Zhang, Yu, primary, Ning, Yanxia, primary, Li, Lin, primary, Hu, Xiaoyan, primary, Chalasani, Sri Lakshmi, primary, Sharma, Kanika, primary, Nkwocha, Jewel, primary, Yu, Jonathan, primary, Bandyopadhyay, Dipankar, primary, Sebti, Said M., primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figures 1 - 2, Tables 1 - 2 from Selective Disruption of Rb–Raf-1 Kinase Interaction Inhibits Pancreatic Adenocarcinoma Growth Irrespective of Gemcitabine Sensitivity

Author

Treviño, José G., primary, Verma, Monika, primary, Singh, Sandeep, primary, Pillai, Smitha, primary, Zhang, Dongyu, primary, Pernazza, Daniele, primary, Sebti, Said M., primary, Lawrence, Nicholas J., primary, Centeno, Barbara A., primary, and Chellappan, Srikumar P., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Data from Chk1 Inhibition Potently Blocks STAT3 Tyrosine705 Phosphorylation, DNA-Binding Activity, and Activation of Downstream Targets in Human Multiple Myeloma Cells

Author

Zhou, Liang, primary, Pei, Xinyan, primary, Zhang, Yu, primary, Ning, Yanxia, primary, Li, Lin, primary, Hu, Xiaoyan, primary, Chalasani, Sri Lakshmi, primary, Sharma, Kanika, primary, Nkwocha, Jewel, primary, Yu, Jonathan, primary, Bandyopadhyay, Dipankar, primary, Sebti, Said M., primary, and Grant, Steven, primary

Published
2023
Full Text
View/download PDF

23. Data from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Author

Marchion, Douglas C., primary, Cottrill, Hope M., primary, Xiong, Yin, primary, Chen, Ning, primary, Bicaku, Elona, primary, Fulp, William J., primary, Bansal, Nisha, primary, Chon, Hye Sook, primary, Stickles, Xiaomang B., primary, Kamath, Siddharth G., primary, Hakam, Ardeshir, primary, Li, Lihua, primary, Su, Dan, primary, Moreno, Carolina, primary, Judson, Patricia L., primary, Berchuck, Andrew, primary, Wenham, Robert M., primary, Apte, Sachin M., primary, Gonzalez-Bosquet, Jesus, primary, Bloom, Gregory C., primary, Eschrich, Steven A., primary, Sebti, Said, primary, Chen, Dung-Tsa, primary, and Lancaster, Johnathan M., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Data S1, S2 from Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors

Author

Kazi, Aslamuzzaman, primary, Xiang, Shengyan, primary, Yang, Hua, primary, Chen, Liwei, primary, Kennedy, Perry, primary, Ayaz, Muhammad, primary, Fletcher, Steven, primary, Cummings, Christopher, primary, Lawrence, Harshani R., primary, Beato, Francisca, primary, Kang, Ya'an, primary, Kim, Michael P., primary, Delitto, Andrea, primary, Underwood, Patrick W., primary, Fleming, Jason B., primary, Trevino, Jose G., primary, Hamilton, Andrew D., primary, and Sebti, Said M., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 8 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 2 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure 1 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Author

Marchion, Douglas C., primary, Cottrill, Hope M., primary, Xiong, Yin, primary, Chen, Ning, primary, Bicaku, Elona, primary, Fulp, William J., primary, Bansal, Nisha, primary, Chon, Hye Sook, primary, Stickles, Xiaomang B., primary, Kamath, Siddharth G., primary, Hakam, Ardeshir, primary, Li, Lihua, primary, Su, Dan, primary, Moreno, Carolina, primary, Judson, Patricia L., primary, Berchuck, Andrew, primary, Wenham, Robert M., primary, Apte, Sachin M., primary, Gonzalez-Bosquet, Jesus, primary, Bloom, Gregory C., primary, Eschrich, Steven A., primary, Sebti, Said, primary, Chen, Dung-Tsa, primary, and Lancaster, Johnathan M., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table 2 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Author

Marchion, Douglas C., primary, Cottrill, Hope M., primary, Xiong, Yin, primary, Chen, Ning, primary, Bicaku, Elona, primary, Fulp, William J., primary, Bansal, Nisha, primary, Chon, Hye Sook, primary, Stickles, Xiaomang B., primary, Kamath, Siddharth G., primary, Hakam, Ardeshir, primary, Li, Lihua, primary, Su, Dan, primary, Moreno, Carolina, primary, Judson, Patricia L., primary, Berchuck, Andrew, primary, Wenham, Robert M., primary, Apte, Sachin M., primary, Gonzalez-Bosquet, Jesus, primary, Bloom, Gregory C., primary, Eschrich, Steven A., primary, Sebti, Said, primary, Chen, Dung-Tsa, primary, and Lancaster, Johnathan M., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 3 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 2 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table 3 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

32. Data from Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins

Author

Wei, Jun, primary, Kitada, Shinichi, primary, Rega, Michele F., primary, Emdadi, Aras, primary, Yuan, Hongbin, primary, Cellitti, Jason, primary, Stebbins, John L., primary, Zhai, Dayong, primary, Sun, Jiazhi, primary, Yang, Li, primary, Dahl, Russell, primary, Zhang, Ziming, primary, Wu, Bainan, primary, Wang, Si, primary, Reed, Tyler A., primary, Lawrence, Nicholas, primary, Sebti, Said, primary, Reed, John C., primary, and Pellecchia, Maurizio, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Data from Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins

Author

Wei, Jun, primary, Kitada, Shinichi, primary, Rega, Michele F., primary, Emdadi, Aras, primary, Yuan, Hongbin, primary, Cellitti, Jason, primary, Stebbins, John L., primary, Zhai, Dayong, primary, Sun, Jiazhi, primary, Yang, Li, primary, Dahl, Russell, primary, Zhang, Ziming, primary, Wu, Bainan, primary, Wang, Si, primary, Reed, Tyler A., primary, Lawrence, Nicholas, primary, Sebti, Said, primary, Reed, John C., primary, and Pellecchia, Maurizio, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Methods from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Author

Marchion, Douglas C., primary, Cottrill, Hope M., primary, Xiong, Yin, primary, Chen, Ning, primary, Bicaku, Elona, primary, Fulp, William J., primary, Bansal, Nisha, primary, Chon, Hye Sook, primary, Stickles, Xiaomang B., primary, Kamath, Siddharth G., primary, Hakam, Ardeshir, primary, Li, Lihua, primary, Su, Dan, primary, Moreno, Carolina, primary, Judson, Patricia L., primary, Berchuck, Andrew, primary, Wenham, Robert M., primary, Apte, Sachin M., primary, Gonzalez-Bosquet, Jesus, primary, Bloom, Gregory C., primary, Eschrich, Steven A., primary, Sebti, Said, primary, Chen, Dung-Tsa, primary, and Lancaster, Johnathan M., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 4 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 1 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

37. Extended Methods from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 6 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Table 7 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

40. Data from Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors

Author

Kazi, Aslamuzzaman, primary, Xiang, Shengyan, primary, Yang, Hua, primary, Chen, Liwei, primary, Kennedy, Perry, primary, Ayaz, Muhammad, primary, Fletcher, Steven, primary, Cummings, Christopher, primary, Lawrence, Harshani R., primary, Beato, Francisca, primary, Kang, Ya'an, primary, Kim, Michael P., primary, Delitto, Andrea, primary, Underwood, Patrick W., primary, Fleming, Jason B., primary, Trevino, Jose G., primary, Hamilton, Andrew D., primary, and Sebti, Said M., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Table 5 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table 1 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Table 6 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Figure 4 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 5 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Author

Pidala, Joseph, primary, Walton, Kelly, primary, Elmariah, Hany, primary, Kim, Jongphil, primary, Mishra, Asmita, primary, Bejanyan, Nelli, primary, Nishihori, Taiga, primary, Khimani, Farhad, primary, Perez, Lia, primary, Faramand, Rawan G., primary, Davila, Marco L., primary, Nieder, Michael L., primary, Sagatys, Elizabeth M., primary, Holtan, Shernan G., primary, Lawrence, Nicholas J., primary, Lawrence, Harshani R., primary, Blazar, Bruce R., primary, Anasetti, Claudio, primary, Sebti, Said M., primary, and Betts, Brian C., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table 1 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Author

Marchion, Douglas C., primary, Cottrill, Hope M., primary, Xiong, Yin, primary, Chen, Ning, primary, Bicaku, Elona, primary, Fulp, William J., primary, Bansal, Nisha, primary, Chon, Hye Sook, primary, Stickles, Xiaomang B., primary, Kamath, Siddharth G., primary, Hakam, Ardeshir, primary, Li, Lihua, primary, Su, Dan, primary, Moreno, Carolina, primary, Judson, Patricia L., primary, Berchuck, Andrew, primary, Wenham, Robert M., primary, Apte, Sachin M., primary, Gonzalez-Bosquet, Jesus, primary, Bloom, Gregory C., primary, Eschrich, Steven A., primary, Sebti, Said, primary, Chen, Dung-Tsa, primary, and Lancaster, Johnathan M., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Table 3 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Author

Marchion, Douglas C., primary, Cottrill, Hope M., primary, Xiong, Yin, primary, Chen, Ning, primary, Bicaku, Elona, primary, Fulp, William J., primary, Bansal, Nisha, primary, Chon, Hye Sook, primary, Stickles, Xiaomang B., primary, Kamath, Siddharth G., primary, Hakam, Ardeshir, primary, Li, Lihua, primary, Su, Dan, primary, Moreno, Carolina, primary, Judson, Patricia L., primary, Berchuck, Andrew, primary, Wenham, Robert M., primary, Apte, Sachin M., primary, Gonzalez-Bosquet, Jesus, primary, Bloom, Gregory C., primary, Eschrich, Steven A., primary, Sebti, Said, primary, Chen, Dung-Tsa, primary, and Lancaster, Johnathan M., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Figure Legends 1-2 from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Author

Cheng, Fengdong, primary, Wang, Hongwei, primary, Horna, Pedro, primary, Wang, Zi, primary, Shah, Bijal, primary, Sahakian, Eva, primary, Woan, Karrune V., primary, Villagra, Alejandro, primary, Pinilla-Ibarz, Javier, primary, Sebti, Said, primary, Smith, Mitchell, primary, Tao, Jianguo, primary, and Sotomayor, Eduardo M., primary

Published
2023
Full Text
View/download PDF

49. Data from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Author

Cheng, Fengdong, primary, Wang, Hongwei, primary, Horna, Pedro, primary, Wang, Zi, primary, Shah, Bijal, primary, Sahakian, Eva, primary, Woan, Karrune V., primary, Villagra, Alejandro, primary, Pinilla-Ibarz, Javier, primary, Sebti, Said, primary, Smith, Mitchell, primary, Tao, Jianguo, primary, and Sotomayor, Eduardo M., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results